搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
ALS News Today
1 天
Avextra to launch Phase 2 trial of cannabis-based medicine in Italy
Avextra plans a Phase 2 trial in Italy to test a cannabis-based oral medicine to ease symptoms in ALS and other ...
ALS News Today
2 天
Highly targeted approach supports ALS gene therapy development
Researchers have developed a type of gene therapy that selectively targets diseased nerve cells in ALS while leaving healthy ...
ALS News Today
3 天
Neuvivo requests FDA approval of ALS treatment NP001
Neuvivo has filed an application with the U.S. Food and Drug Administration (FDA) requesting the approval of its ...
ALS News Today
5 天
Differences in tears can distinguish bulbar-onset ALS vs. spinal-onset
Differences in human tears in ALS can distinguish bulbar-onset disease from spinal-onset ALS, making this a possible ...
ALS News Today
4 天
FGF4 shows benefits in ALS but fails to protect motor neurons
In an ALS study, growth factor FGF4 reduced the activity of star-shaped cells called astrocytes but did not stop motor ...
ALS News Today
9 天
Target ALS, Modality.AI partner to study AI in ALS
Modality.AI and Target ALS are partnering on a clinical study of AI as a way to assess changes in speech and motor function ...
ALS News Today
8 天
Immune proteins activation at ALS diagnosis linked to progression
Changes in the production of several immune proteins at the time of an ALS diagnosis were linked to disease progression in ...
ALS News Today
10 天
PrimeC, potential ALS treatment, given US patent for its formulation
The new patent covers Neurosense's formulation of PrimeC, a fixed-dose combo of an approved antibiotic and anti-inflammatory.
ALS News Today
4 天
Good memories sustain us when life with ALS is hard
The past is always present, we're told, and that's a comfort for columnist Kristin Neva when she can focus on good memories from before ALS.
ALS News Today
11 天
Phase 1 trial of prosetin to create digital twins of ALS patients
ProJenX teamed with Unlearn to create digital twins of ALS patients as a placebo group in open-label extension of Phase 1 ...
ALS News Today
12 天
Mayo Clinic awarded $22M grant to study ibudilast in ALS patients
The Mayo Clinic was awarded $12 million to support a study that will give ALS patients access to the investigational therapy ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈